ChinYang Chemical Corporation
KRX:051630.KS
2835 (KRW) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 28,281.408 | 29,090.014 | 34,785.241 | 43,288.27 | 44,531.589 | 49,730.594 | 49,592.413 | 57,610.216 | 70,795.247 | 79,319.654 | 70,268.217 | 64,375.84 | 62,756.797 | 57,926.457 | 53,114.736 | 52,782.555 | 45,845.916 |
| Cost of Revenue
| 25,580.931 | 26,423.69 | 34,057.601 | 38,399.1 | 42,264.665 | 44,526.119 | 44,242.231 | 49,708.424 | 60,290.759 | 66,511.527 | 58,721.169 | 55,278.794 | 55,204.105 | 52,080.02 | 45,431.328 | 45,899.753 | 40,205.179 |
| Gross Profit
| 2,700.477 | 2,666.323 | 727.64 | 4,889.17 | 2,266.924 | 5,204.475 | 5,350.181 | 7,901.792 | 10,504.489 | 12,808.126 | 11,547.048 | 9,097.046 | 7,552.691 | 5,846.437 | 7,683.408 | 6,882.802 | 5,640.737 |
| Gross Profit Ratio
| 0.095 | 0.092 | 0.021 | 0.113 | 0.051 | 0.105 | 0.108 | 0.137 | 0.148 | 0.161 | 0.164 | 0.141 | 0.12 | 0.101 | 0.145 | 0.13 | 0.123 |
| Reseach & Development Expenses
| 312.725 | 120.823 | 170.064 | 145.512 | 93.96 | 153.612 | 100.072 | 72.619 | 91.974 | 105.32 | 118.106 | 155.563 | 183.578 | 211.368 | 208.435 | 177.742 | 207.563 |
| General & Administrative Expenses
| 845.908 | 279.016 | 258.136 | 267.858 | 310.054 | 313.892 | 366.171 | 489.918 | 550.275 | 573.338 | 537.284 | 479.838 | 454.844 | 416.955 | 395.188 | 374.645 | 389.661 |
| Selling & Marketing Expenses
| 1,620.502 | 1,418.099 | 1,805.509 | 2,004.984 | 2,197.071 | 2,298.891 | 2,476.277 | 2,694.166 | 3,440.709 | 2,504.355 | 2,864.227 | 2,657.56 | 2,617.027 | 2,474.136 | 2,339.273 | 2,300.83 | 2,106.063 |
| SG&A
| 4,534.967 | 1,697.115 | 2,063.645 | 2,272.842 | 2,507.124 | 2,612.784 | 2,842.448 | 3,184.084 | 3,990.984 | 3,077.693 | 3,401.511 | 3,137.398 | 3,071.872 | 2,891.091 | 2,734.461 | 2,675.475 | 2,495.724 |
| Other Expenses
| 119.254 | 1,904.015 | 2,350.258 | 2,274.612 | 2,411.332 | 135.363 | 57.476 | 114.788 | 58.282 | 315.974 | -192.527 | -473.466 | 2,579.369 | 349.441 | 138.002 | 287.675 | 201.091 |
| Operating Expenses
| 4,847.692 | 3,721.953 | 4,583.967 | 4,692.966 | 5,012.416 | 5,792.297 | 6,021.613 | 6,615.51 | 7,642.918 | 6,753.732 | 6,442.237 | 6,126.876 | 5,834.818 | 5,829.815 | 5,637.983 | 5,465.493 | 5,213.7 |
| Operating Income
| -2,147.216 | -1,055.629 | -3,856.328 | 196.205 | -2,745.493 | -587.822 | -671.432 | 1,286.282 | 2,861.57 | 6,054.395 | 5,104.812 | 2,970.17 | 1,726.01 | 16.624 | 2,045.426 | 1,417.311 | 427.035 |
| Operating Income Ratio
| -0.076 | -0.036 | -0.111 | 0.005 | -0.062 | -0.012 | -0.014 | 0.022 | 0.04 | 0.076 | 0.073 | 0.046 | 0.028 | 0 | 0.039 | 0.027 | 0.009 |
| Total Other Income Expenses Net
| -44.564 | -183.406 | 2,291.89 | 601.151 | -88.89 | 21.627 | 100.113 | 153.334 | -297.78 | 542.448 | -125.818 | -428.319 | -63.175 | 422.057 | 307.638 | -301.79 | 255.142 |
| Income Before Tax
| -2,191.78 | -1,239.035 | -1,564.438 | 1,146.106 | -2,834.383 | -566.195 | -571.319 | 1,439.616 | 2,964.674 | 6,596.843 | 4,978.994 | 2,541.851 | 1,662.835 | 438.681 | 2,353.064 | 1,115.521 | 682.177 |
| Income Before Tax Ratio
| -0.077 | -0.043 | -0.045 | 0.026 | -0.064 | -0.011 | -0.012 | 0.025 | 0.042 | 0.083 | 0.071 | 0.039 | 0.026 | 0.008 | 0.044 | 0.021 | 0.015 |
| Income Tax Expense
| -21.084 | -126.228 | 648.225 | 320.004 | -738.33 | -234.747 | -233.004 | 127.257 | 397.686 | 1,349.552 | 1,398.012 | 176.115 | 157.863 | -148.336 | 363.762 | 213.4 | 75.149 |
| Net Income
| -2,170.695 | -1,112.808 | -2,212.663 | 826.102 | -2,096.053 | -331.448 | -338.315 | 1,312.36 | 2,566.988 | 5,247.291 | 3,580.982 | 2,365.735 | 1,504.972 | 587.018 | 1,989.302 | 1,530.094 | 1,902.285 |
| Net Income Ratio
| -0.077 | -0.038 | -0.064 | 0.019 | -0.047 | -0.007 | -0.007 | 0.023 | 0.036 | 0.066 | 0.051 | 0.037 | 0.024 | 0.01 | 0.037 | 0.029 | 0.041 |
| EPS
| -137.39 | -82.95 | -170.22 | 63.55 | -161.25 | -25.85 | -26.03 | 100.62 | 197.56 | 403.42 | 275.1 | 193.86 | 115.39 | 45.23 | 153.24 | 117.7 | 73.39 |
| EPS Diluted
| -137.39 | -82.95 | -170.22 | 63.55 | -161.25 | -25.85 | -25.85 | 100.62 | 197.56 | 403.42 | 275.1 | 193.86 | 115.39 | 45.23 | 153.24 | 117.7 | 73.39 |
| EBITDA
| -1,096.318 | -706.383 | -939.143 | 1,851.49 | -2,001.896 | 431.652 | 577.764 | 2,664.088 | 3,948.751 | 7,081.633 | 6,030.445 | 3,540.346 | 2,686.629 | 1,827.492 | 3,468.799 | 2,361.701 | 2,136.957 |
| EBITDA Ratio
| -0.039 | -0.013 | -0.088 | 0.022 | -0.04 | 0.013 | 0.011 | 0.046 | 0.057 | 0.094 | 0.084 | 0.055 | 0.043 | 0.032 | 0.064 | 0.044 | 0.047 |